Featured Posts
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs,…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager…
Search Posts
Op-Eds
Is the U.S. Sugar Problem Solvable?
The United States’ sugar policy has a long history of supporting sugar producers, and the current system has its roots in the agricultural programs of…
Op-Eds
Top Ten Junk Science Stories of the Past Decade
My web site JunkScience.com celebrated its 10th anniversary on April 1, 2006. To mark the event, this column spotlights…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY Executives from major oil companies testify before Congress on industry profits. CEI Expert Available…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. BUSINESS AT&T announces a merger with BellSouth, pending approval by the FCC and U.S. Justice Department.
Op-Eds
The Lancet Pricks Itself
The term “medical journals” elicits automatic respect from most people. Not from me: I read them. I've found the editors to be increasingly…
Op-Eds
WTO and Biotech Food: Who Really Won?
The long-awaited World Trade Organization decision on biotechnology applied to agricultural products, finally released earlier this month, elicited a great deal of buzz…